isolated from the cells were labeled and analyzed on
). All of the tested genes were activated after 12 hr to the similar level of 24 hr. Signifi-
NFI/CTF Participates in the Activation of CSF1 cant activation of CSF1 and CRYAB was observed in
Promoter by the BAF Complex as little as 6 hr after BRG1 transfection. FACS analysis In order to identify the DNA elements that mediate the showed that the distribution of the cell cycle position BAF complex activity, we performed a systematic 5Ј was identical between transfected and nontransfected deletion analysis of CSF1 promoter. A promoter concells after 24 hr of Brg1 transfection (data not shown), struct containing sequences up to Ϫ2600 showed simiindicating that the expression level change in these lar basal activity and inducibility with the Ϫ350 sequence genes did not result from the cell cycle position shift (data not shown). Deletion to Ϫ150 and Ϫ130 reduced following Brg1 transfection. its basal level activity, while the activation by the BAF complex remained similar (about 4.7-fold), as shown in Figure 2B . The reduction of basal activity is presumably Activation of CSF1 Promoter by the BAF Complex Is Chromatin Dependent caused by deletion of several Sp1 sites that exist between Ϫ350 and Ϫ150. However, further deletion to Ϫ85 The finding that CSF1 gene was significantly activated within 6 hr of transfection of BRG1 in SW-13 cells (Figure reduced the activation by BAF complex to about 2.2-fold, while the basal level activity remained the same. 1C) suggests that the BAF complex might directly regulate the expression of CSF1 gene. CSF1 is implicated Deletion of another 25 base pairs completely eliminated the activation by the BAF complex ( Figure 2B ). Therein the regulation of the proliferation, differentiation, and survival of macrophages (Stanley et al., 1983) . More fore, the BAF complex-responsive elements in CSF1 promoter are located between the Ϫ130 and Ϫ60 regions. recent data suggest that it may be involved in tumor progression and metastasis (Lin et by the BAF complex. A probe encompassing the NFI/ To determine if the NFI binding site is functionally involved in the activation of CSF1 promoter by the BAF CTF site was shifted by SW-13 cell nuclear extracts in gel mobility shift assay (EMSA), which was supershifted complex, we tested the CSF1 promoter with the same mutations shown in Figure 3A in the transfection experiby an antibody against human CTF ( Figure 3B , lanes 2 and 3). 100-fold excess of consensus NFI site and wildment. Interestingly, the mutations inhibited the activation of the promoter by the BAF complex in SW-13 cells type NFI site from CSF1 promoter efficiently competed NFI binding to the wild-type NFI probe ( Figure 3C , lanes ( Figure 3D) . We therefore conclude that NFI/CTF binding site is required for the activation of CSF1 promoter by 2, 3, and 4), while the mutations shown in Figure 3A significantly reduced its ability for the competition (lanes the BAF complex. 5 and 6). Mutation of both of the half binding sites completely abolished its ability to compete with the wild-NFI/CTF and BAF Complex Bind to the CSF1 Promoter In Vivo type probe (data not shown). Furthermore, the mutant probes had much lower affinity for NFI compared to In order to determine if NFI/CTF and the BAF complex bind to CSF1 promoter in vivo, we performed chromatin wild-type probe as detected by EMSA (data not shown). We hypothesized that the NFI binding could be important for the association of BAF complex with CSF1 promoter. To test this idea, we transfected either wild-type or NFI site-mutated CSF1 promoter constructs in pREP4 vector into MG63 cells that have both NFI and the BAF complex and can be transfected with higher efficiency than WI-38 cells. As shown by ChIP assay in Figure 4C , both NFI and BAF complex were bound to the wild-type CSF1 promoter construct ( Figure 4C , lanes 4, 5, and 6), 
1999). In order to determine if it is
we treated the supercoiled and linear constructs with the TG repeats sequence or its potential to form Z DNA DEPC which attacks the exposed DNA backbone in the that enables CSF1 promoter to be activated by the BAF Z-DNA conformation. As shown in Figure 5C , primer complex, we replaced the TG repeats with another Z extension of DEPC-treated supercoiled 18GC construct DNA-forming sequence, 18 GC repeats, or a random produced a strong band of about 160 to 180 base pairs sequence from BAF47 gene. As shown in Figure 5B , the corresponding to the position of the 18 GC repeats, 18GC construct showed similar activity with the wildsuggesting a Z-DNA conformation of the 18 GC repeat type CSF1 promoter in the presence of the BAF complex, DNA sequence. Linearization of the plasmid eliminated while the activity of the construct with the random sethe Z-DNA conformation (compare lanes 3 and 4). The quence in place of the TG repeats (labeled as NoTG) wild-type CSF1 promoter construct gave a weaker was significantly reduced. These experiments indicate Z-DNA signal than the 18GC construct (compare lanes that it is the Z-DNA forming potential but not the particu-1 and 2), while Z-DNA formation was eliminated in the lar TG repeats sequence that is required for the maximal TG-deletion construct (lanes 5 and 6). activation of CSF1 promoter by BAF complex.
These results show that the TG repeats and the GC repeats, both of which are capable of mediating activaThe TG Repeats in CSF1 Promoter Form Z DNA tion of the CSF1 promoter by BAF complex, are also in Supercoiled Plasmids capable of forming Z-DNA structure in supercoiled plas-Z-DNA structure can be stabilized by negative supercoiling in closed circular plasmid, most readily in sequences mid DNA. Figure 5E ). Dependent on the exact site of bind-siently exposed TG repeats by inducing Z-DNA formation. To test this idea, we assembled 260 bp of CSF1 promoter sequence into nucleosomes. To minimize dinucleosome formation, we used a lower donor oligonucleosome/DNA ratio, which favors mononucleosome formation (data not shown), presumably randomly placed on the CSF1 promoter sequence such as templates 2 and 3 in Figure 6A . As shown in Figure 6C , Zaa induced degradation of the templates that presumably consisted of either free DNA or nucleosomal DNA with exposed TG repeats such as templates 1 and 2 in Figure  6A ( Figure 6C, lanes 2 and 3) . Surprisingly, treatment with BAF complex also induced the template degradation (compare lanes 2 and 4). This observation is consistent with the recently reported activity for the BAF complex that it induces superhelical torsion in DNA or chromatin template (Havas et al., 2000; Gavin et al.,  2001 ) that, in turn, could stabilize a Z-DNA-like structure. Interestingly, the presence of both Zaa protein and BAF complex was more efficient at inducing the template degradation, therefore, Z-DNA formation ( Figure 6C , lane 5). To confirm that the cleavages induced by Zaa-FOK are occurring at the TG repeats, we labeled the reaction products by primer extension from the opposite end of the TG repeats, which generated a major band of about 200 bp, consistent with the cleavage within the TG repeats ( Figure 6D) .
From these results, we conclude that nucleosomal structure inhibits B-to Z-DNA conversion and that BAF complex facilitates Z-DNA formation in a nucleosomal template.
Discussion
Using the DNA microarray, we identified 80 genes which were induced more than 3-fold and 2 genes which were were washed sequentially four times with RIPA buffer containing 0.3 M NaCl, once with RIPA buffer containing no NaCl, and once with 1ϫ TE. Following reverse-crosslinking at 65ЊC for 6 hr, DNA ELISA was purified by proteinase K digestion, phenol-chloroform extracEqual numbers of SW-13 and MG63 cells were plated in DMEM in tion and ethanol precipitation. DNA was resuspended in 20 l of 1ϫ 24-well plate at 2 ϫ 10 5 cells/ml and incubated at 37ЊC for 24 hr. TE and 4 l was used for PCR analysis. To determine CSF1 production, 100 l of the culture medium was incubated for 12 hr at 4ЊC in a 96-well plate coated with 200 ng of goat anti-human CSF1 antibody (Sigma), followed by five washes Acknowledgments with 1ϫ PBS ϩ 0.05% Tween20. The plate was incubated with 100 l of 50 ng/ml biotinylated goat anti-human CSF1 antibody (R&D We thank Gerald R. Crabtree, Warren J. Leonard, and Carl Wu for critical reading of the manuscript and members of the Leonard and Systems) in 1ϫ PBS ϩ 0.1% BSA for 1.5 hr at room temperature and washed as before. Following incubation with Streptavidin-HRP Zhao laboratories for discussion. We thank Naoko Tanese 
